Home >
Medicine Info >
Gitune 150 MG Tablet SR
Loading interface...

Gitune 150 MG Tablet SR

Manufactured byIntas Pharmaceuticals Ltd.
ContainsItopride
Description
Gitune 150 MG Tablet SR is used to increase the mobility of food in the stomach and intestine. It is used for the treatment of gastrointestinal symptoms such as abdominal pain, loss of appetite, heartburn, nausea, vomiting, etc. associated with gastroesophageal reflux disease, functional dyspepsia, and other associated motility disorders.
QUICK LINKS:
Side effectsConcernsUsageRelated products

Substitutes

List of substitutes for Gitune 150 MG Tablet SR

Ganaton 150 MG Tablet SR
Abbott India Ltd.
Itza 150 MG Tablet SR
Cadila Pharmaceuticals Ltd.

Side effects

Major & minor side effects for Gitune 150 MG Tablet SR

  • Diarrhea
  • Headache
  • Decrease in white blood cells and platelets
  • Breast enlargement in men
  • Skin rash
  • Increased liver enzyme levels in the blood
  • Jaundice
  • Constipation
  • Increased salivation
  • Dizziness

Uses of Gitune 150 MG Tablet SR

What is it prescribed for?

  • Non-ulcer dyspepsia
  • Gastroparesis
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for this medicine to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of side effects.
  • Is this a habit forming medicine?
    No habit forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. The risks and benefits should be discussed with the doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before taking this medicine.

Allergy

This medicine is not recommended for use in patients with a known history of allergy to itopride or any other inactive ingredients present along with the formulation.

Gastrointestinal hemorrhage

This medicine is not recommended for use in patients having internal bleeding of the stomach and intestine. This may be attributed to various reasons including a ruptured bowel (Gastrointestinal Perforation).

Mechanical bowel obstruction

This medicine is not recommended for use in patients having a blockage in the intestine.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. The risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before taking this medicine.
General warnings

Use in elderly population

This medicine should be used with extreme caution in elderly patients above 65 years of age due to the risk of adverse effects. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Bleeding of stomach and intestine

Report any instance indicating bleeding of the stomach like the presence of blood in stools, black or coffee-colored stools to the doctor immediately. This medicine should not be used if bleeding is evident or even suspected.

Other medicines

This medicine may interact with many other medicines and may cause severe adverse effects. Hence, it is advised that you inform the doctor about all your current medicines including any herbs and supplements before beginning treatment with this medicine.

Gastrointestinal perforation diseases

This medicine is not recommended in patients suffering from gastrointestinal hemorrhage, mechanical obstruction, or perforation diseases due to the increased risk of severe adverse effects. Replacement with a suitable alternative may be required in some cases based on the clinical condition.

Missed Dose

Take the missed dose as soon as you remember. The missed dose can be skipped if it is almost time for the next scheduled dose.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of side effects.
Interaction with Medicine

Anticholinergic drugs

Disease interactions

Disease

Information not available.
Food interactions
Consumption of grapefruit juice or grapefruit is not recommended while taking this medicine due to an increased risk of side effects. Consult the doctor if you experience any undesirable side effects.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Take this medicine exactly as advised by the doctor. It can be taken 15 minutes before a meal. Do not take in larger amounts than prescribed. Consult the doctor if you experience any undesirable side effects.
Miscelleneous

To be taken before food

To be taken as instructed by doctor

May cause sleepiness

How it works
This medicine acts by increasing the concentration of chemicals at the nerve endings causing an increase in stomach muscle movement. This helps in the faster movement of food from the stomach to the intestine.
Legal Status

Approved

Unknown

Unknown

Unknown

Classification

Category

Gastrointestinal agents

Schedule

Schedule H

Shenoy KT e. Efficacy and tolerability of itopride hydrochloride in patients with non-ulcer dyspepsia. - PubMed - NCBI [Internet]. Ncbi.nlm.nih.gov. 2017 [cited 24 March 2017]. Available from:

https://www.ncbi.nlm.nih.gov/pubmed/14579989

Itopride | C20H26N2O4 - PubChem [Internet]. Pubchem.ncbi.nlm.nih.gov. 2017 [cited 24 March 2017]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/3792#section=Top

Itopride - DrugBank [Internet]. Drugbank.ca. 2020 [cited 17 March 2020]. Available from:

https://www.drugbank.ca/drugs/DB04924
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 17 Apr 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.